Steven Oliveira
Presidente presso Oliveira Capital LLC
Patrimonio netto: 311 682 $ in data 30/04/2024
Profilo
Steven M.
Oliveira is the founder of SIGA Technologies, Inc. founded in 1995.
He is also the founder of Assertio Therapeutics, Inc. Mr. Oliveira's current job is President at Oliveira Capital LLC since 2002.
Mr. Oliveira's former jobs include Director at Repros Therapeutics, Inc., Director at Ideanomics, Inc. from 2010 to 2011, Independent Director at Pulte Acquisition Corp., Chief Investment Officer at Chardan SPAC Asset Management LLC from 2008 to 2013, and Managing Partner at CSO Ventures.
Mr. Oliveira received his undergraduate degree from Manhattan College in 1989.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
BENITEC BIOPHARMA INC
0.48% | 22/04/2024 | 44 911 ( 0.48% ) | 311 682 $ | 30/04/2024 |
Posizioni attive di Steven Oliveira
| Società | Posizione | Inizio |
|---|---|---|
| Oliveira Capital LLC | Presidente | 01/01/2002 |
Precedenti posizioni note di Steven Oliveira
| Società | Posizione | Fine |
|---|---|---|
| Chardan SPAC Asset Management LLC | Direttore degli Investimenti | 01/01/2013 |
| IDEANOMICS, INC. | Direttore/Membro del Consiglio | 30/03/2011 |
| REPROS THERAPEUTICS INC | Direttore/Membro del Consiglio | - |
| SIGA TECHNOLOGIES, INC. | Fondatore | - |
| CSO Ventures | Corporate Officer/Principal | - |
Formazione di Steven Oliveira
| Manhattan College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SIGA TECHNOLOGIES, INC. | Health Technology |
| IDEANOMICS, INC. | Consumer Durables |
| Aziende private | 6 |
|---|---|
Repros Therapeutics, Inc.
 Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
| Oliveira Capital LLC | |
| Chardan SPAC Asset Management LLC | |
Pulte Acquisition Corp.
 Pulte Acquisition Corp. MiscellaneousMiscellaneous Pulte Acquisition Corp. operates as a blank check company. The company is headquartered in Chicago, IL. | Miscellaneous |
| CSO Ventures |
- Borsa valori
- Insiders
- Steven Oliveira